18.95
+0.40
+(2.16%)
As of 12:29:58 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
39,779
39,779
25,847
23,647
38,899
Cost of Revenue
197,404
197,404
189,842
170,909
158,269
Gross Profit
-157,625
-157,625
-163,995
-147,262
-119,370
Operating Expense
198,502
198,502
156,473
170,818
174,612
Operating Income
-356,127
-356,127
-320,468
-318,080
-293,982
Net Non Operating Interest Income Expense
-28,424
-28,424
-29,169
-21,111
-18,692
Pretax Income
-368,207
-368,207
-337,987
-327,877
-301,756
Net Income Common Stockholders
-368,207
-368,207
-337,987
-327,877
-301,756
Diluted NI Available to Com Stockholders
-368,207
-368,207
-337,987
-327,877
-301,756
Basic EPS
-2.68
--
-2.81
-2.82
-2.89
Diluted EPS
-2.68
--
-2.81
-2.82
-2.89
Basic Average Shares
137,390.67
--
120,280.07
116,133
104,402.42
Diluted Average Shares
137,390.67
--
120,280.07
116,133
104,402.42
Total Expenses
395,906
395,906
346,315
341,727
332,881
Net Income from Continuing & Discontinued Operation
-368,207
-368,207
-337,987
-327,877
-301,756
Normalized Income
-368,207
-368,207
-337,987
-327,877
-301,756
Interest Income
5,734
5,734
4,422
1,929
848
Interest Expense
34,158
34,158
33,591
23,040
19,540
Net Interest Income
-28,424
-28,424
-29,169
-21,111
-18,692
EBIT
-334,049
-334,049
-304,396
-304,837
-282,216
EBITDA
-246,696
-246,696
-219,585
-219,482
-196,920
Reconciled Cost of Revenue
197,404
197,404
189,842
170,909
158,269
Reconciled Depreciation
87,353
87,353
84,811
85,355
85,296
Net Income from Continuing Operation Net Minority Interest
-368,207
-368,207
-337,987
-327,877
-301,756
Normalized EBITDA
-246,696
-246,696
-219,585
-219,482
-196,920
12/31/2021 - 7/15/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4168.TWO GlycoNex Incorporation
17.05
+3.65%
4130.TWO Genovate Biotechnology Co., Ltd.
20.55
+2.24%
3118.TWO Level Biotechnology Inc.
31.60
+1.77%
6492.TWO Senhwa Biosciences, Inc.
33.40
+1.98%
6733.TWO BioGend Therapeutics Co., Ltd.
26.00
+1.38%
3205.TWO Sagittarius Life Science Corp
23.90
+5.29%
6662.TWO BioLASCO Taiwan Co., Ltd.
32.50
+1.56%
4726.TWO Mycenax Biotech Inc.
32.20
+3.38%
8279.TWO Syngen Biotech Co.,Ltd.
119.50
+0.84%
4728.TWO Sunmax Biotechnology Co., Ltd.
388.00
+1.44%